# HALLEY Venture Partners

> HALLEY Venture Partners is a VC fund backing Cannabis and Biotechnology. See 15 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Lafayette, United States
- Total investments: 15
- Last investment: Feb 2022
- Lead investor: 20%
- Fund size: $8M
- Last fund: Feb 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/halley-venture-partners
- Website: https://www.halleyvp.com/

HALLEY Venture Partners is a VC fund in Lafayette focused on Cannabis and Biotechnology. HALLEY brings together a diverse group of financial professionals, engineers, scientists, lawyers, media guru's, cultivators, sales specialists, software experts, and many others. We look to find the next crop of super companies and their visionary founders. We aim to nurture them when needed and stand aside when they are flourishing.

## Contacts

5 contacts available for HALLEY Venture Partners. Shizune tracks 1 team members at HALLEY Venture Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/halley-venture-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.1M–$3.1M |
| Series B | $7.5M–$19M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Cannabis | 4 | 27% |
| Biotechnology | 4 | 27% |
| Medical | 2 | 13% |
| Blockchain | 2 | 13% |
| Agriculture | 2 | 13% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 33% |
| Series B | 3 | 20% |
| Funding Round | 3 | 20% |
| Series A | 1 | 7% |
| Convertible Note | 1 | 7% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 7 | 47% |
| Mexico | 1 | 7% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Steve Schuman | Founder & Managing Director | 6 | https://shizune.co/investors/profile/steve-schuman |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Willow Industries | Willow Industries provides cutting edge technology for post-harvest microbial decontamination in cannabis. Based in Denver, CO, they provide state-of-the-art technology to clean and purify flower & trim. Their patent-pending machine, WillowPure, uses ozone-based oxidation to reduce mold, yeast, mildew, Aspergillus, Salmonella, E. Coli andother potential pathogens. All while protecting the medicinal properties, aroma, potency and visual appearance of the flower. | $2M | Series A | Feb 23, 2022 |  |
| Lucid Green | Lucid Green enables the cannabis industry to communicate trust and transparency through a direct connection with the consumer. It gives brands a direct-to-consumer and direct-to-budtender marketing channel while incentivizing brands and their suppliers to provide accurate and timely product information. As a blockchain solution, all actions bydata uploaders and data consumers are governed and driven by a sophisticated, immutable ledger and a token economy. It was founded in 2018 and is headquartered in New York, New York. | $3.1M |  | May 11, 2021 |  |
| Lucid Green | Lucid Green enables the cannabis industry to communicate trust and transparency through a direct connection with the consumer. It gives brands a direct-to-consumer and direct-to-budtender marketing channel while incentivizing brands and their suppliers to provide accurate and timely product information. As a blockchain solution, all actions bydata uploaders and data consumers are governed and driven by a sophisticated, immutable ledger and a token economy. It was founded in 2018 and is headquartered in New York, New York. | $3.1M | Seed | May 11, 2021 |  |
| springbig | Springbig provides loyalty, digital communications, and CRM technology solutions to retailers in the cannabis industry. It was founded in 2012 and is headquartered in Boca Raton, Florida. After years of experience in big-box retail, their founders saw tremendous opportunity in the underserved cannabis industry and decided to bring advanced loyaltyprograms, an essential marketing tool in such a competitive industry, to cannabis dispensaries and brands. | $11.5M | Series B | Aug 11, 2020 |  |
| RICOVR Healthcare | RICOVR Healthcare is a medical device company that has developed a biosensor technology for rapid point-of-care testing. The company’s non-invasive portable testing devices will benefit not only employers and law enforcement but also the medical community and individuals. The novel patented technology is extremely sensitive and can quantitativelydetect disease biomarkers even present in low quantity. They are currently developing testing devices for THC (psychoactive component of Cannabis) and COVID-19. In addition, the platform has the potential to add accurate and quantitative testing for alcohol, other drugs of abuse, and infectious diseases. | $1.1M | Seed | Apr 29, 2020 |  |
| Front Range Biosciences | Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $18.7M | Series B | Feb 14, 2020 |  |
| Zassy | The creator economy is exploding and millions of creators waste 70% of their time managing platforms vs. creating products that drive revenue. With 20% marketplace commissions, 90% of creators aren’t profitable and don’t leverage new Blockchain chain revenue streams. They’re ready for a new solution. Zassy redefines how creators buy & sellphysical & digital products (NFTs) and turn their craft into a tradable asset. Zassy is a full-service eCommerce, NFT, and blockchain IPO solution for the creator economy. For one low monthly fee, creators receive their own digital wallet, a fully-managed eGallery, and Zassy Creator Tokens to showcase themselves and their products. Zassy is a full-service experience for the creator economy that hasn't existed until now.Zassy is the first of its kind. A platform built by creators, for creators, is setting the standard for brilliant creators all over the world.To learn more about Zassy, visit www.zassy.com or email info@zassy.com.We provide consumers an elegant and streamlined digital social commerce experience while connecting with like-minded people from around the world via a customizable social feed. | $605K | Convertible Note | Feb 01, 2020 |  |
| PathogenDx | PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $7.5M | Series B | Sep 30, 2019 |  |
| Front Range Biosciences | Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $8.5M | Series B | Sep 16, 2019 |  |
| Willow Industries | Willow Industries provides cutting edge technology for post-harvest microbial decontamination in cannabis. Based in Denver, CO, they provide state-of-the-art technology to clean and purify flower & trim. Their patent-pending machine, WillowPure, uses ozone-based oxidation to reduce mold, yeast, mildew, Aspergillus, Salmonella, E. Coli andother potential pathogens. All while protecting the medicinal properties, aroma, potency and visual appearance of the flower. | $2M |  | Jun 12, 2019 |  |

10 of 15 investments shown.

## Co-investors
- [Salveo Capital](https://shizune.co/investors/profile/salveo-capital) — VC Fund, 5 deals together
- [AFI Capital Partners](https://shizune.co/investors/profile/afi-capital-partners) — VC Fund, 3 deals together
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund, 3 deals together
- [Sand Hill Angels](https://shizune.co/investors/profile/sand-hill-angels) — VC Fund, 3 deals together
- [Silverleaf Venture Partners](https://shizune.co/investors/profile/silverleaf-venture-partners) — VC Fund, 3 deals together
- [WelCan Capital](https://shizune.co/investors/profile/welcan-capital) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Casa Verde Capital](https://shizune.co/investors/profile/casa-verde-capital) — VC Fund
- [Poseidon Asset Management](https://shizune.co/investors/profile/poseidon-assetmanagement) — VC Fund
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Canary](https://shizune.co/investors/profile/canary-5) — VC Fund
- [DOMO.VC](https://shizune.co/investors/profile/domo-invest) — VC Fund

## Featured in investor lists
- [Cannabis VC Funds](https://shizune.co/investors/cannabis-vc-funds)
- [Cannabis Investors in United States](https://shizune.co/investors/cannabis-investors-united-states)
- [Cannabis VC Funds in United States](https://shizune.co/investors/cannabis-vc-funds-united-states)
- [Cannabis Investors](https://shizune.co/investors/cannabis-investors)
- [Biotechnology Investors in LATAM](https://shizune.co/investors/biotechnology-investors-latam)
- [Biotechnology VC Funds in LATAM](https://shizune.co/investors/biotechnology-vc-funds-latam)

## FAQ

### What does HALLEY Venture Partners invest in?

HALLEY Venture Partners invests primarily in Cannabis, Biotechnology and Medical startups, most often at Seed and Series B stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is HALLEY Venture Partners's check size?

HALLEY Venture Partners typically joins rounds of $1.1M–$3.1M at Seed and $7.5M–$19M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HALLEY Venture Partners participates in.

### How do I contact HALLEY Venture Partners?

Public channels for HALLEY Venture Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at HALLEY Venture Partners?

The team at HALLEY Venture Partners includes Steve Schuman (Founder & Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co